Wafford KA[au] - Search Results

Year	Number of Results
1986	1
1987	2
1988	1
1989	3
1990	1
1991	1
1992	3
1993	5
1994	5
1995	4
1996	3
1997	5
1998	1
1999	4
2000	4
2001	5
2002	5
2003	7
2004	11
2005	11
2006	21
2007	2
2008	3
2009	2
2010	3
2011	4
2012	3
2013	2
2014	2
2015	2
2016	5
2017	8
2018	3
2019	2
2020	1
2021	0

1

The role of K₂p channels in anaesthesia and sleep.

Steinberg EA, Wafford KA, Brickley SG, Franks NP, Wisden W. Steinberg EA, et al. Among authors: wafford ka. Pflugers Arch. 2015 May;467(5):907-16. doi: 10.1007/s00424-014-1654-4. Epub 2014 Dec 9. Pflugers Arch. 2015. PMID: 25482669 Free PMC article. Review.

2

Gaboxadol--a new awakening in sleep.

Wafford KA, Ebert B. Wafford KA, et al. Curr Opin Pharmacol. 2006 Feb;6(1):30-6. doi: 10.1016/j.coph.2005.10.004. Epub 2005 Dec 20. Curr Opin Pharmacol. 2006. PMID: 16368265 Review.

3

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.

Holton CM, Hanley N, Shanks E, Oxley P, McCarthy A, Eastwood BJ, Murray TK, Nickerson A, Wafford KA. Holton CM, et al. Among authors: wafford ka. Alzheimers Res Ther. 2020 Jul 15;12(1):84. doi: 10.1186/s13195-020-00651-0. Alzheimers Res Ther. 2020. PMID: 32669112 Free PMC article.

4

New directions in kinetic high information content assays.

Simpson PB, Wafford KA. Simpson PB, et al. Among authors: wafford ka. Drug Discov Today. 2006 Mar;11(5-6):237-44. doi: 10.1016/s1359-6446(05)03696-2. Drug Discov Today. 2006. PMID: 16639807 Review. No abstract available.

5

Treating insomnia: Current and investigational pharmacological approaches.

Ebert B, Wafford KA, Deacon S. Ebert B, et al. Among authors: wafford ka. Pharmacol Ther. 2006 Dec;112(3):612-29. doi: 10.1016/j.pharmthera.2005.04.014. Epub 2006 Jul 28. Pharmacol Ther. 2006. PMID: 16876255 Review.

6

Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time.

Wafford KA, Ebert B. Wafford KA, et al. Nat Rev Drug Discov. 2008 Jun;7(6):530-40. doi: 10.1038/nrd2464. Epub 2008 May 23. Nat Rev Drug Discov. 2008. PMID: 18511929 Review.

7

GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence?

Wafford KA. Wafford KA. Curr Opin Pharmacol. 2005 Feb;5(1):47-52. doi: 10.1016/j.coph.2004.08.006. Curr Opin Pharmacol. 2005. PMID: 15661625 Review.

8

Structure and pharmacology of vertebrate GABAA receptor subtypes.

Whiting PJ, McKernan RM, Wafford KA. Whiting PJ, et al. Among authors: wafford ka. Int Rev Neurobiol. 1995;38:95-138. doi: 10.1016/s0074-7742(08)60525-5. Int Rev Neurobiol. 1995. PMID: 8537206 Review. No abstract available.

9

Prevalence and influence of cys407* Grm2 mutation in Hannover-derived Wistar rats: mGlu2 receptor loss links to alcohol intake, risk taking and emotional behaviour.

Wood CM, Nicolas CS, Choi SL, Roman E, Nylander I, Fernandez-Teruel A, Kiianmaa K, Bienkowski P, de Jong TR, Colombo G, Chastagnier D, Wafford KA, Collingridge GL, Wildt SJ, Conway-Campbell BL, Robinson ES, Lodge D. Wood CM, et al. Among authors: wafford ka. Neuropharmacology. 2017 Mar 15;115:128-138. doi: 10.1016/j.neuropharm.2016.03.020. Epub 2016 Mar 14. Neuropharmacology. 2017. PMID: 26987983 Free article. Review.

10

Differentiating the role of gamma-aminobutyric acid type A (GABAA) receptor subtypes.

Wafford KA, Macaulay AJ, Fradley R, O'Meara GF, Reynolds DS, Rosahl TW. Wafford KA, et al. Biochem Soc Trans. 2004 Jun;32(Pt3):553-6. doi: 10.1042/BST0320553. Biochem Soc Trans. 2004. PMID: 15157182 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results